	Cost-effective Mueller matrix microscopy for label-free differentiation of melanoma from normal skin and common skin cancer types. Biomed Opt Express Du Le VN, Bolden A. PMID: 41394488 [PubMed]
	Preoperative primary tumor SUVmax on PET/CT correlates with Breslow thickness and is associated with survival in melanoma: A retrospective cohort study. JAAD Int Chang YH, Huang YH, Pan SC, Yu-Yun Lee J, Wu CL, Wong TW, Lu HH, Liu WT. PMID: 41393353 [PubMed]
	Toward Precision Medicine: Gene Therapy Applications in the Management of Uveal Melanoma. Cancer Rep (Hoboken) Azani A, Ghassemifar V, Mehrdad Z, Saberivand M, Bagheripour A, Tahmasebi S, Gharedaghi H, Sharafi M, Foroozand H, Soleimani Meigoli MS, Pourali S, Salmaninejad A, Ahmadi Beni F, Behfar Q. PMID: 41392397 [PubMed - indexed for MEDLINE]
	Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma. Nat Commun Pedersen S, Byrdal M, Martinenaite E, Lorentzen CL, Kjeldsen JW, Thorsen SU, Kverneland A, Zocca MB, Andersen MH, Svane IM. PMID: 41392152 [PubMed - as supplied by publisher]
	Interpreting Deep Learning-based Prediction of BRAF V600E Mutation using Diagnostic Whole Slide Images in Skin Cutaneous Melanoma. Am J Pathol Rao VR, Nguyen V, Phung TL, Sukhadia SS. PMID: 41391751 [PubMed - as supplied by publisher]
	Comparable Disease-Specific Survival between Mohs Surgery and Wide Local Excision for Acral Lentiginous Melanoma: A National Cohort Study. J Am Acad Dermatol Taylor MA, Beach L, McGrath J, Shelton E, Sharma D, Wysong A. PMID: 41391633 [PubMed - as supplied by publisher]
	Longitudinal Risk of Cutaneous Squamous Cell Carcinoma Development Following PD-1 Inhibitor Therapy for Melanoma: A Retrospective TriNetX Cohort Study. J Am Acad Dermatol Nusrat F, Lauck K, Jennings T, Lawrence N. PMID: 41390131 [PubMed - as supplied by publisher]
	Current and emerging opportunities for deintensification of systemic therapies in melanoma: A scoping review. Eur J Cancer Soon JA, Franchini F, Gourlay P, IJzerman MJ, McArthur GA. PMID: 41389770 [PubMed - as supplied by publisher]
	Higher Socioeconomic Status and Physician Accessibility Linked to More Early-stage but Not Fewer Late-Stage Melanoma Diagnoses. Clin Exp Dermatol Dong W, Kim U, Montgomery B, Lal T, Liu L, Kakish H, Rose J, Koroukian SM, Bordeaux JS, Rothermel LD, Hoehn RS. PMID: 41388790 [PubMed - as supplied by publisher]
	Characteristics and overall survival in patients with T1 melanoma: A nationwide matched cohort study. Int J Cancer Naeser Y, Mikiver R, Isaksson K, Lambe M, Ullenhag GJ. PMID: 41386727 [PubMed - as supplied by publisher]
	Progress in immunotherapy for resectable head and neck squamous cell carcinoma. Med Oncol Li J, Pan B, Tai Y. PMID: 41385149 [PubMed - indexed for MEDLINE]
	Pathological features, differential diagnosis, prognosis, and diagnostic challenges in the classification of penile squamous neoplasia. Histopathology Rodriguez I, Fernandez-Nestosa MJ, Sanchez D, Cubilla AL. PMID: 41384715 [PubMed - indexed for MEDLINE]
	Frequency of Oral Squamous Cell Carcinoma in Two Public Hospitals in Peru: A Ten-Year Retrospective Study. Oral Health Prev Dent Villar-Rivera M, Asian-Suarez PE, Cruz-Colca JB, Dulanto-Vargas JA. PMID: 41384448 [PubMed - indexed for MEDLINE]
	Multi-cohort validation based on coagulation-related genes for predicting prognosis of esophageal squamous cell carcinoma. Front Immunol Wang R, Zhang W, Li X, Wang H, Ji Y, Zhao J, Song J, Yi Z. PMID: 41383582 [PubMed - indexed for MEDLINE]
	Prognostic factors of oral squamous cell carcinoma: a five-year retrospective study in Cluj-Napoca, Romania. Rom J Morphol Embryol Moldovan MA, Neghin, Bumbu BA, Precup AI, Vica, , Roman CR, Cump. PMID: 41382954 [PubMed - indexed for MEDLINE]
	Assessment of the clinical and morphological characteristics of visceral melanoma metastases and primary extracutaneous melanomas. Rom J Morphol Embryol Natarâ, Dema ALC, Jurescu A, Vi, T, Hurmuz I, Szilagyi DN, Grujic D, Popa VT, Dema S. PMID: 41382944 [PubMed - indexed for MEDLINE]
	Methylated CfDNA may distinguish between high- and intermediate-risk uveal melanoma: a pilot study. Cancer Cell Int Wu M, de Bruyn DP, Boers RG, Beasley AB, Hazelaar DM, Makrodimitris S, Boers JB, Vaarwater J, de Keizer ROB, Verdijk RM, Naus NC, Paridaens D, Wilting SM, Gray ES, van IJcken WFJ, Gribnau J, de Klein A, Brosens E, Kiliç E, Rotterdam Ocular Melanoma Studygroup. PMID: 41382221 [PubMed - as supplied by publisher]
	Peripheral blood cells predict the efficacy and prognosis of neoadjuvant immunotherapy combined with chemotherapy for esophageal squamous cell carcinoma. BMC Cancer Ran X, Zhang C, Zheng L, Luo T, Xu B, Zhang Y, Zhang L, Yang B, Fu M. PMID: 41382073 [PubMed - indexed for MEDLINE]
	Sorafenib plus selective internal radiotherapy with (90)Y resin microspheres for the treatment of uveal melanoma with liver metastasis: a phase I trial. Br J Cancer Berthod G, Cisarovsky C, Petrova T, Decosterd LA, Choong E, Celestini D, Cuendet MA, Boughdad S, Prior JO, Meuwly JY, Figg WD, Michielin O, Leyvraz S. PMID: 41381843 [PubMed - as supplied by publisher]
	Adjuvant immunotherapy in esophageal squamous cell carcinoma after radiotherapy: retrospective multicentric survival analysis. Dis Esophagus Zeng W, Long J, Tan B, Li Y, Zhang J, Tang Q, He Y. PMID: 41378887 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 140412

Page 1 of 7021



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy